Stargardt Disease Market to Grow Rapidly at a CAGR of 32% by 2034 | DelveInsight [Yahoo! Finance]
Belite Bio, Inc - American Depositary Shares (BLTE)
Company Research
Source: Yahoo! Finance
Owing to the positive outcomes of several products during the developmental stage by key players such as Alkeus Pharmaceuticals, Kubota Pharmaceuticals, Nanoscope Therapeutics, and others. LAS VEGAS April 24, 2024 /PRNewswire/ -- DelveInsight's Stargardt Disease Market Insights report includes a comprehensive understanding of current treatment practices, Stargardt disease emerging drugs, market share of individual therapies, and current and forecasted market size from 2020 to 2034, segmented into 7MM [ the United States , the EU4 ( Germany France Italy , and Spain ) and the United Kingdom , and Japan ]. Key Takeaways from the Stargardt Disease Market Report According to DelveInsight's analysis, the market size for Stargardt disease reached ~ USD 28 million in 2023 across the 7MM. In 2023, the United States accounted for the highest number of Stargardt disease cases, which is of the diagnosed-prevalent cases of Stargardt disease in the 7MM. Leading Stargardt disease companies
Show less
Read more
Impact Snapshot
Event Time:
BLTE
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
BLTE alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
BLTE alerts
High impacting Belite Bio, Inc - American Depositary Shares news events
Weekly update
A roundup of the hottest topics
BLTE
News
- Belite Bio Announces Presentation at the Association for Research in Vision and Ophthalmology 2024 Annual MeetingGlobeNewswire
- Belite Bio Announces $25 Million Registered Direct Offering [Yahoo! Finance]Yahoo! Finance
- Belite Bio Announces $25 Million Registered Direct OfferingGlobeNewswire
- Stargardt Disease Market to Grow Rapidly at a CAGR of 32% by 2034 | DelveInsightPR Newswire
- Stargardt Disease Market to Grow Rapidly at a CAGR of 32% by 2034 | DelveInsightPR Newswire
BLTE
Earnings
- 3/11/24 - Beat
BLTE
Sec Filings
- 4/29/24 - Form 424B5
- 4/26/24 - Form 6-K
- 3/22/24 - Form 144
- BLTE's page on the SEC website